Oppenheimer & CO Inc Charles River Laboratories International, Inc. Transaction History

Oppenheimer & CO Inc

$6.52 Billion
Q4 2024

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 06, 2024	BUY	$203.52 - $273.43 $355,142 - $477,135	1,745 New	1,745 $472,000
Q4 2022 Feb 07, 2023	BUY	$197.11 - $250.07 $292,905 - $371,604	1,486 New	1,486 $323,000
Q1 2022 May 12, 2022	SELL	$255.51 - $362.11 $417,758 - $592,049	-1,635 Closed	0 $0
Q4 2021 Feb 02, 2022	BUY	$351.38 - $448.68 $62,545 - $79,865	178 Added 12.22%	1,635 $616,000
Q3 2021 Nov 12, 2021	SELL	$372.64 - $458.3 $1,863 - $2,291	-5 Reduced 0.34%	1,457 $601,000
Q2 2021 Aug 03, 2021	BUY	$294.17 - $371.65 $10,001 - $12,636	34 Added 2.38%	1,462 $541,000
Q1 2021 May 10, 2021	SELL	$249.67 - $299.48 $289,367 - $347,097	-1,159 Reduced 44.8%	1,428 $414,000
Q4 2020 Feb 11, 2021	SELL	$222.0 - $252.62 $666 - $757	-3 Reduced 0.12%	2,587 $646,000
Q3 2020 Nov 13, 2020	SELL	$175.56 - $226.45 $4,037 - $5,208	-23 Reduced 0.88%	2,590 $587,000
Q2 2020 Aug 11, 2020	BUY	$118.84 - $189.72 $64,767 - $103,397	545 Added 26.35%	2,613 $456,000
Q1 2020 May 08, 2020	SELL	$98.9 - $178.34 $105,031 - $189,397	-1,062 Reduced 33.93%	2,068 $261,000
Q4 2019 Feb 07, 2020	SELL	$126.05 - $152.76 $5,042 - $6,110	-40 Reduced 1.26%	3,130 $478,000
Q2 2019 Aug 09, 2019	SELL	$123.4 - $148.55 $10,365 - $12,478	-84 Reduced 2.58%	3,170 $450,000
Q1 2019 Apr 24, 2019	SELL	$104.82 - $146.73 $4,926 - $6,896	-47 Reduced 1.42%	3,254 $473,000
Q4 2018 Jan 29, 2019	SELL	$105.09 - $137.23 $26,167 - $34,170	-249 Reduced 7.01%	3,301 $374,000
Q3 2018 Oct 26, 2018	BUY	$112.11 - $134.54 $96,750 - $116,108	863 Added 32.12%	3,550 $478,000
Q2 2018 Aug 10, 2018	BUY	$102.37 - $117.25 $1,126 - $1,289	11 Added 0.41%	2,687 $302,000
Q1 2018 May 01, 2018	BUY	$98.19 - $115.2 $262,756 - $308,275	2,676 New	2,676 $286,000

Others Institutions Holding CRL

# of Institutions

704

Shares Held

50.8M

Call Options Held

122K

Put Options Held

239K

Vanguard Group Inc Valley Forge, PA

6.16M
Shares

$657 Million
0.02% of portfolio
Black Rock Inc. New York, NY

5.09M
Shares

$542 Million
0.02% of portfolio
State Street Corp Boston, MA

2.18M
Shares

$233 Million
0.02% of portfolio
Allspring Global Investments Holdings, LLC

1.81M
Shares

$193 Million
0.56% of portfolio
Kayne Anderson Rudnick Investment Management LLC Los Angeles, CA

1.81M
Shares

$192 Million
0.79% of portfolio

View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

Ticker CRL
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 50,863,300
Market Cap $5.42B
Description
Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...

More about CRL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Oppenheimer & CO Inc, based on Form 13F filings with the SEC.

News

Stay updated on Oppenheimer & CO Inc with notifications on news.

Account